Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Chardan Capital

EyePoint Pharmaceuticals Inc.
Start price
€15.48
04.03.26 / 50%
Target price
€25.00
04.03.27
Performance (%)
-70.27%
Price
€11.40
14.08.26
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -70.27%. This prediction currently runs until 04.03.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. 4.587% 4.587%
iShares Core DAX® -0,05 % 5,96 %
iShares Nasdaq 100 0,92 % 3,69 %
iShares Nikkei 225® 3,01 % 6,64 %
iShares S&P 500 -0,36 % 2,75 %

Comments by Chardan_Capital for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -70.27%
Target price 25.004
Change
Ends at 04.03.27

Eyepoint Pharmaceuticals (EYPT) had its price target raised by Chardan Capital from $27.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat

Chardan Capital 
0
Report Share
04.03.26

Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.94
17.08.26
€56.13
17.08.27
17.77%
14.08.26

Chardan Capital 
17.08.26 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.80
07.08.26
€56.41
07.08.27
-61.02%
14.08.26

Chardan Capital 
07.08.26 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.10
01.07.26
€57.00
01.07.27
-64.58%
14.08.26

Chardan Capital 
01.07.26 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.77
07.08.25
€23.15
07.08.26
36.80%
08.08.26

Chardan Capital 
07.08.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.43
08.05.25
€23.84
08.05.26
111.94%
09.05.26

Chardan Capital 
08.05.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.23
06.03.25
€30.59
06.03.26
109.90%
07.03.26

Chardan Capital 
06.03.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.36
06.02.25
€31.85
06.02.26
83.31%
07.02.26

Chardan Capital 
06.02.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.87
08.11.24
€30.77
08.11.25
-12.71%
09.11.25

Chardan Capital 
08.11.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.28
29.10.24
€25.95
29.10.25
0.68%
30.10.25

Chardan Capital 
29.10.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.25
28.06.24
€26.15
28.06.25
-1.07%
29.06.25

Chardan Capital 
28.06.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.92
07.05.24
€25.98
07.05.25
-45.28%
08.05.25

Chardan Capital 
07.05.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.30
03.08.23
€20.11
03.08.24
-37.17%
04.08.24

Chardan Capital 
03.08.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%